{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T17:09:16Z","timestamp":1649178556985},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2010,7,22]],"date-time":"2010-07-22T00:00:00Z","timestamp":1279756800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s00415-010-5667-4","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T18:47:41Z","timestamp":1279651661000},"page":"1788-1797","source":"Crossref","is-referenced-by-count":2,"title":["Current issues in antiplatelet therapy for stroke prevention: the importance of stroke subtypes and differences between stroke and MI patients"],"prefix":"10.1007","volume":"257","author":[{"given":"H. S.","family":"Kirshner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,22]]},"reference":[{"key":"5667_CR1","unstructured":"American Heart Association\/American Stroke Association. Heart Disease and Stroke Statistics (2009) Update at-a-glance. http:\/\/www.americanheart.org\/downloadable\/heart\/1240250946756LS-1982%20Heart%20and%20Stroke%20Update.042009.pdf . Accessed 28 Jul 2009"},{"key":"5667_CR2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1468-1331.2006.01138.x","volume":"13","author":"T Truelsen","year":"2006","unstructured":"Truelsen T, Piechowski-Jozwiak B, Bonita R et al (2006) Stroke incidence and prevalence in Europe: a review of available data. Eur J Neurol 13:581\u2013598","journal-title":"Eur J Neurol"},{"key":"5667_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2008.12.012","volume":"279","author":"HS Kirshner","year":"2009","unstructured":"Kirshner HS (2009) Differentiating ischemic stroke subtypes: risk factors and secondary prevention. J Neurol Sci 279:1\u20138","journal-title":"J Neurol Sci"},{"key":"5667_CR4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1159\/000210432","volume":"27","author":"P Amarenco","year":"2009","unstructured":"Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG (2009) Classification of stroke subtypes. Cerebrovasc Dis 27:493\u2013501","journal-title":"Cerebrovasc Dis"},{"key":"5667_CR5","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/01.STR.0000157949.34986.30","volume":"36","author":"C Jackson","year":"2005","unstructured":"Jackson C, Sudlow C (2005) Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and nonlacunar infarcts. Stroke 36:891\u2013901","journal-title":"Stroke"},{"key":"5667_CR6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd (1993) Classification of subtype of acute ischemic stroke. Definition for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35\u201341","journal-title":"Stroke"},{"key":"5667_CR7","first-page":"S204","volume":"14","author":"M Fisher","year":"2008","unstructured":"Fisher M (2008) Stroke and TIA: epidemiology, risk factors, and the need for early intervention. Am J Managed Care 14:S204\u2013S211","journal-title":"Am J Managed Care"},{"key":"5667_CR8","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1161\/hs1101.098524","volume":"32","author":"AJ Grau","year":"2001","unstructured":"Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S, Glahn J, Brandt T, Hacke W, Diener HC (2001) Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke 32:2559\u20132566","journal-title":"Stroke"},{"key":"5667_CR9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/pgmj.2007.066563","volume":"84","author":"NU Weir","year":"2008","unstructured":"Weir NU (2008) An update on cardioembolic stroke. Postgrad Med J 84:133\u2013142","journal-title":"Postgrad Med J"},{"key":"5667_CR10","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3122\/jabfm.18.6.528","volume":"18","author":"HS Kirshner","year":"2005","unstructured":"Kirshner HS, Biller J, Callahan AS (2005) Long-term therapy to prevent stroke. J Am Board Fam Prac 18:528\u2013540","journal-title":"J Am Board Fam Prac"},{"key":"5667_CR11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000113864","volume":"25","author":"T Leoo","year":"2008","unstructured":"Leoo T, Lindgren A, Petersson J, von Arbin M (2008) Risk factors and treatment at recurrent stroke onset: results from the Recurrent Stroke Quality and Epidemiology (RESQUE) Study. Cerebrovasc Dis 25:254\u2013260","journal-title":"Cerebrovasc Dis"},{"key":"5667_CR12","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1161\/01.CIR.0000157736.19739.D0","volume":"111","author":"H White","year":"2005","unstructured":"White H, Boden-Albala B, Wang C, Elkind MS, Rundek T, Wright CB, Sacco RL (2005) Ischemic stroke subtype incidence among whites, blacks, and Hispanics. The Northern Manhattan Study. Circulation 111:1327\u20131331","journal-title":"Circulation"},{"key":"5667_CR13","first-page":"14","volume":"2","author":"A Taqui","year":"2007","unstructured":"Taqui A, Kamal AK (2007) Stroke in Asians. Pak J Neurol Sci 2:14\u201317","journal-title":"Pak J Neurol Sci"},{"key":"5667_CR14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/01.STR.0000199147.30016.74","volume":"37","author":"RL Sacco","year":"2006","unstructured":"Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T, American Heart Association; American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology (2006) Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association\/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 37:577\u2013617","journal-title":"Stroke"},{"key":"5667_CR15","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1161\/01.STR.0000072985.24967.7F","volume":"34","author":"T Hillen","year":"2003","unstructured":"Hillen T, Coshall C, Tilling K, Rudd AG, McGovern R, Wolfe CD, South London Stroke Register (2003) Cause of stroke recurrence is multifactorial: patterns, risk factors, and outcomes of stroke recurrence in the South London register. Stroke 34:1457\u20131463","journal-title":"Stroke"},{"key":"5667_CR16","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1161\/STROKEAHA.107.503094","volume":"39","author":"E Touz\u00e9","year":"2008","unstructured":"Touz\u00e9 E, Coste J, Voicu M, Kansao J, Masmoudi R, Doumenc B, Durieux P, Mas JL (2008) Importance of in-hospital initiation of therapies and therapeutic inertia in secondary stroke prevention. IMplementaion of Prevention After a Cerebrovascular event (IMPACT) study. Stroke 39:1834\u20131843","journal-title":"Stroke"},{"key":"5667_CR17","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/hs1201.100209","volume":"32","author":"PL Kolominsky-Rabas","year":"2001","unstructured":"Kolominsky-Rabas PL, Weber M, Gefellar O, Neundoerfer B, Heuschmann PU (2001) Epidemiology of ischemic subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke 32:2735\u20132740","journal-title":"Stroke"},{"key":"5667_CR18","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1161\/01.STR.0000239694.19359.88","volume":"37","author":"T Ohira","year":"2006","unstructured":"Ohira T, Shahar E, Chambless LE, Rosamond WD, Mosley TH Jr, Folsom AR (2006) Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities Study. Stroke 37:2493\u20132498","journal-title":"Stroke"},{"key":"5667_CR19","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1161\/01.STR.0000128794.30660.e8","volume":"35","author":"T Mannami","year":"2004","unstructured":"Mannami T, Iso H, Baba S, Sasaki S, Okada K, Konishi M, Tsugane S, Japan Public Health Center-Based Prospective Study on Cancer and Cardiovascular Disease Group (2004) Cigarette smoking and risk of stroke and its subtypes among middle-aged Japanese men and women: the JPHC Study Cohort I. Stroke 35:1248\u20131253","journal-title":"Stroke"},{"key":"5667_CR20","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.jacc.2003.12.047","volume":"43","author":"JA Ambrose","year":"2004","unstructured":"Ambrose JA, Barua RS (2004) The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 43:1731\u20131737","journal-title":"J Am Coll Cardiol"},{"key":"5667_CR21","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1161\/01.STR.0000075294.98582.2F","volume":"34","author":"SH Suk","year":"2003","unstructured":"Suk SH, Boden-Albala B, Cheun JF et al (2003) Abdominal obesity and risk of ischemic stroke: The Northern Manhattan Stroke Study. Stroke 34:1586\u20131592","journal-title":"Stroke"},{"key":"5667_CR22","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1001\/archneur.62.3.386","volume":"62","author":"S Ruland","year":"2005","unstructured":"Ruland S, Hung E, Richardson D, Misra S, Gorelick PB, African American Antiplatelet Stroke Prevention Study Investigators (2005) Impact of obesity and the metabolic syndrome on risk factors in African American stroke survivors. Arch Neurol 62:386\u2013390","journal-title":"Arch Neurol"},{"key":"5667_CR23","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1212\/01.wnl.0000180600.09719.53","volume":"65","author":"L Dauchet","year":"2005","unstructured":"Dauchet L, Amouyel P, Dallongeville J (2005) Fruit and vegetable consumption and risk of stroke: a meta-analysis of cohort studies. Neurology 65:1193\u20131197","journal-title":"Neurology"},{"key":"5667_CR24","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/jama.285.3.304","volume":"285","author":"H Iso","year":"2001","unstructured":"Iso H, Rexrode K, Stampfer M, Manson JE, Colditz GA, Speizer FE, Hennekens CH, Willett WC (2001) Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA 285:304\u2013312","journal-title":"JAMA"},{"key":"5667_CR25","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1001\/jama.288.24.3130","volume":"288","author":"K He","year":"2002","unstructured":"He K, Rimm E, Merchant A, Rosner BA, Stampfer MJ, Willett WC, Ascherio A (2002) Fish consumption and risk of stroke in men. JAMA 288:3130\u20133136","journal-title":"JAMA"},{"key":"5667_CR26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1212\/01.wnl.0000324414.12665.b0","volume":"71","author":"JK Virtanen","year":"2008","unstructured":"Virtanen JK, Siscovick DS, Longstreth WT Jr, Kuller LH, Mozaffarian D (2008) Fish consumption and risk of subclinical brain abnormalities on MRI in older adults. Neurology 71:439\u2013446","journal-title":"Neurology"},{"key":"5667_CR27","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1161\/STROKEAHA.109.555136","volume":"40","author":"SD Poppitt","year":"2009","unstructured":"Poppitt SD, Colin AH, Lithander FE, Silvers KM, Lin RB, Croft J, Ratnasabapathy Y, Gibson RA, Anderson CS (2009) Effects of moderate-dose omega-3 fish oil on cardiovascular risk factors and mood after ischemic stroke. Stroke 40:3485\u20133492","journal-title":"Stroke"},{"key":"5667_CR28","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/ana.10722","volume":"54","author":"M Endres","year":"2003","unstructured":"Endres M, Gertz K, Lindauer U, Katchanov J, Schultze J, Schr\u00f6ck H, Nickenig G, Kuschinsky W, Dirnagl U, Laufs U (2003) Mechanisms of stroke protection by physical activity. Ann Neurol 54:582\u2013590","journal-title":"Ann Neurol"},{"key":"5667_CR29","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1161\/STROKEAHA.108.527978","volume":"40","author":"AJ Grau","year":"2009","unstructured":"Grau AJ, Barth C, Geletneky B, Ling P, Palm F, Lichy C, Becher H, Buggle F (2009) Association between recent sports activity, sports activity in young adulthood, and stroke. Stroke 40:426\u2013431","journal-title":"Stroke"},{"key":"5667_CR30","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1161\/01.STR.30.12.2513","volume":"30","author":"GW Petty","year":"1999","unstructured":"Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O\u2019Fallon WM, Wiebers DO (1999) Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke 30:2513\u20132516","journal-title":"Stroke"},{"key":"5667_CR31","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1212\/01.wnl.0000294323.48661.a9","volume":"70","author":"OY Bang","year":"2008","unstructured":"Bang OY, Saver JL, Liebeskind DS, Pineda S, Ovbiagele B (2008) Association of serum lipid indices with large artery atherosclerotic stroke. Neurology 70:841\u2013847","journal-title":"Neurology"},{"key":"5667_CR32","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1468-1331.2004.00811.x","volume":"11","author":"K Matz","year":"2004","unstructured":"Matz K, Tatschi C, Sebek K, Dachenhausen A, Brainin M (2004) Dyslipidemia, elevated LDL cholesterol and reduced nocturnal blood pressure dipping denote lacunar strokes occurring during nighttime [abstract]. Eur J Neurol 11:742\u2013748","journal-title":"Eur J Neurol"},{"key":"5667_CR33","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1161\/01.STR.0000057975.15221.40","volume":"34","author":"S-E Megherbi","year":"2003","unstructured":"Megherbi S-E, Milan C, Minier D, Couvreur G, Osseby GV, Tilling K, Di Carlo A, Inzitari D, Wolfe CD, Moreau T, Giroud M, European BIOMED Study of Stroke Care Group (2003) Association between diabetes and stroke subtype on survival and functional outcome 3\u00a0months after stroke: data from the European BIOMED Stroke Project. Stroke 34:688\u2013694","journal-title":"Stroke"},{"key":"5667_CR34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2377-5-9","volume":"5","author":"A Arboix","year":"2005","unstructured":"Arboix A, Rivas A, Garc\u00eda-Eroles L, de Marcos L, Massons J, Oliveres M (2005) Cerebral infarction in diabetes: clinical pattern, stroke subtypes, and predictors of in-house mortality. BMC Neurol 5:9","journal-title":"BMC Neurol"},{"key":"5667_CR35","unstructured":"National Stroke Association. Recurrent stroke prevention. http:\/\/www.stroke.org\/site\/DocServer\/Recurrent.pdf?docID=961 . Accessed 31 Jul 2009"},{"key":"5667_CR36","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1161\/01.STR.31.5.1062","volume":"31","author":"GW Petty","year":"2000","unstructured":"Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O\u2019Fallon WM, Wiebers DO (2000) Ischemic stroke subtypes: a population-based study of functional outcome, survival, and recurrence. Stroke 31:1062\u20131068","journal-title":"Stroke"},{"key":"5667_CR37","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1212\/01.WNL.0000110311.09970.83","volume":"62","author":"JK Lovett","year":"2004","unstructured":"Lovett JK, Coull AJ, Rothwell PM (2004) Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 62:569\u2013573","journal-title":"Neurology"},{"key":"5667_CR38","first-page":"362","volume":"32","author":"JM Tobias","year":"2005","unstructured":"Tobias JM, Azarbal B (2005) Does patent foramen ovale promote cryptogenic stroke and migraine headache? Curr Issues Cardiol 32:362\u2013365","journal-title":"Curr Issues Cardiol"},{"key":"5667_CR39","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1161\/01.CIR.0000017498.88393.44","volume":"105","author":"S Homma","year":"2002","unstructured":"Homma S, Sacco RL, DiTullio MR, Sciacca RR, Mohr JP, for the PFO in Cryptogenic Stroke Study (PICSS) Investigators (2002) Effect of medical treatment in stroke patients with patent foramen ovale: patent foreman ovale in cryptogenic stroke study. Circulation 105:2625\u20132631","journal-title":"Circulation"},{"key":"5667_CR40","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1212\/01.wnl.0000201253.93811.f6","volume":"66","author":"MS Dhamoon","year":"2006","unstructured":"Dhamoon MS, Sciacca RR, Rundek T, Sacco RL, Elkind MS (2006) Recurrent stroke and cardiac risks after first ischemic stroke: the Northern Manhattan Study. Neurology 66:641\u2013646","journal-title":"Neurology"},{"key":"5667_CR41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jns.2007.07.025","volume":"264","author":"AM Basile","year":"2008","unstructured":"Basile AM, Di Carlo A, Lamassa M, Baldereschi M, Carlucci G, Consoli D, Wolfe CD, Giroud M, Inzitari D, European BIOMED Study of Stroke Care Group (2008) Selective risk factors profiles and outcomes among patients with stroke and history of prior myocardial infarction. J Neurol Sci 264:87\u201392","journal-title":"J Neurol Sci"},{"issue":"S3","key":"5667_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0140-6736(98)90086-1","volume":"352","author":"CP Warlow","year":"1998","unstructured":"Warlow CP (1998) Epidemiology of stroke. Lancet 352(S3):1\u20134","journal-title":"Lancet"},{"issue":"3","key":"5667_CR43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1155\/MI.2005.175","volume":"2005","author":"A Arakelyan","year":"2005","unstructured":"Arakelyan A, Petrkova J, Hermanova Z, Boyajyan A, Lukl J, Petrek M (2005) Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction. Mediators Inflamm 2005(3):175\u2013179","journal-title":"Mediators Inflamm"},{"key":"5667_CR44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MJT.0b013e31816a61bb","volume":"15","author":"M Fisher","year":"2008","unstructured":"Fisher M, Folland E (2008) Acute ischemic coronary artery disease and ischemic stroke: similarities and differences. Am J Ther 15:137\u2013149","journal-title":"Am J Ther"},{"key":"5667_CR45","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1001\/jama.288.11.1388","volume":"288","author":"SE Strauss","year":"2002","unstructured":"Strauss SE, Majumdar SR, McAlister (2002) New evidence for stroke prevention: scientific review. JAMA 288:1388\u20131395","journal-title":"JAMA"},{"key":"5667_CR46","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0140-6736(93)92358-Z","volume":"342","author":"European Atrial Fibrillation Trial Study Group","year":"1993","unstructured":"European Atrial Fibrillation Trial Study Group (1993) Secondary prevention in no-rheumatic atrial fibrillation after transient ischemic attack or minor stroke. Lancet 342:1255\u20131262","journal-title":"Lancet"},{"key":"5667_CR47","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","volume":"367","author":"SJ Connolly","year":"2006","unstructured":"ACTIVE Writing Group of the ACTIVE Investigators, Connolly SJ, Progue J, Hart RG, Pfeffer M, Hohnloser S, Chloravicius S, Pfeffer M, Hohnloser S, Yusuf S (2006) Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Active fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W). Lancet 367:1903\u20131912","journal-title":"Lancet"},{"issue":"3","key":"5667_CR48","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.STR.0000258004.64840.0b","volume":"38","author":"PT Akins","year":"2007","unstructured":"Akins PT, Feldman HA, Zoble RG, Newman D, Spitzer SG, Diener HC et al (2007) Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials. Stroke 38(3):874\u2013880","journal-title":"Stroke"},{"key":"5667_CR49","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMoa0901301","volume":"360","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Yusuf S, Camm J, the Active investigators study group (2009) Effect of clopidogrel added to aspirin in patients with atrial fibrillation (ACTIVE A). N Engl J Med 360:2066\u20132078","journal-title":"N Engl J Med"},{"key":"5667_CR50","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S, the RE_LY Investigators (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139\u20131151","journal-title":"N Engl J Med"},{"key":"5667_CR51","unstructured":"Diener HC, Connolly S, Ezekowitz MD et al. (2010) Dabigatran compared to warfarin in patients with atrial fibrillation and prior TIA or stroke: results of RE-LY. In: American Stroke Association International Stroke conference 2010, February 26, 2010, San Antonio, TX, USA, Abstract 195"},{"key":"5667_CR52","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1212\/01.WNL.0000119173.15878.F3","volume":"62","author":"SR Mess\u00e9","year":"2004","unstructured":"Mess\u00e9 SR, Silverman IE, Kizer JR, Homma S, Zahn C, Gronseth G, Kasner SE, Quality Standards Subcommittee of the American Academy of Neurology (2004) Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 62:1042\u20131050","journal-title":"Neurology"},{"key":"5667_CR53","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/archinte.167.2.117","volume":"167","author":"F Dentali","year":"2007","unstructured":"Dentali F, Douketis JD, Lim W, Crowther M (2007) Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials. Arch Intern Med 167:117\u2013124","journal-title":"Arch Intern Med"},{"key":"5667_CR54","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMoa011258","volume":"345","author":"JP Mohr","year":"2001","unstructured":"Mohr JP, Thompson JLP, Lazar RM, Levin B, Sacco RL, Furie KL, Kistler JP, Albers GW, Pettigrew LC, Adams HP Jr, Jackson CM, Pullicino P, Warfarin-Aspirin Recurrent Stroke Study Group (2001) A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 345:1444\u20131451","journal-title":"N Engl J Med"},{"key":"5667_CR55","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa003199","volume":"345","author":"F Catella-Lawson","year":"2001","unstructured":"Catella-Lawson F, Reilly MP, Kapoor SC, Cucchiara AJ, DeMarco S, Tournier B, Vyas SN, FitzGerald GA (2001) Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 345:1809\u20131817","journal-title":"N Engl J Med"},{"key":"5667_CR56","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/01.STR.0000057813.31798.1F","volume":"34","author":"N Vartiainem","year":"2003","unstructured":"Vartiainem N, Goldsteins G, Keksa-Golsteine V, Chan PH, Koistinnaho J (2003) Aspirin inhibits p44\/42 mitogen-activated protein kinase and is protective against hypoxia\/reoxygenation neuronal damage. Stroke 34:752\u2013757","journal-title":"Stroke"},{"key":"5667_CR57","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"Antiplatelet Trialists\u2019 Collaboration","year":"2002","unstructured":"Antiplatelet Trialists\u2019 Collaboration (2002) Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients. BMJ 324:71\u201386","journal-title":"BMJ"},{"key":"5667_CR58","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jacc.2005.05.039","volume":"46","author":"AL Frelinger III","year":"2005","unstructured":"Frelinger AL III, Michelson AD (2005) Clopidogrel: linking evaluation of platelet response variability to mechanism of action. J Am Coll Cardiol 46:646\u2013647","journal-title":"J Am Coll Cardiol"},{"key":"5667_CR59","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","volume":"348","author":"CAPRIE Steering Committee","year":"1996","unstructured":"CAPRIE Steering Committee (1996) A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348:1329\u20131339","journal-title":"Lancet"},{"key":"5667_CR60","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","volume":"345","author":"S Yusuf","year":"2001","unstructured":"Yusuf S, Zhao F, Mehta SR, Chloravicius S, Tognoni G, Fox KK, Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators (2001) Clopidogrel in unstable angina to prevent recurrent events (CURE) trial investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345:494\u2013502","journal-title":"N Engl J Med"},{"key":"5667_CR61","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa050522","volume":"352","author":"MS Sabatine","year":"2005","unstructured":"Sabatine MS, Cannon CP, Gibson CM, L\u00f3pez-Send\u00f3n JL, Montalescot G, Theroux P, Claeys MJ, Cools F, Hill KA, Skene AM, McCabe CH, Braunwald E, CLARITY-TIMI 28 Investigators (2005) Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 352:1179\u20131189","journal-title":"N Engl J Med"},{"key":"5667_CR62","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(05)67660-X","volume":"366","author":"ZM Chen","year":"2005","unstructured":"Chen ZM, Jiang LX, Chen YP, Xie JX, Pan HC, Peto R, Collins R, Liu LS, COMMIT (Clopidogrel and Metoprolol in Myocardial Infarction Trial) Collaborative Group (2005) Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomized placebo-controlled trial. Lancet 366:1607\u20131621","journal-title":"Lancet"},{"key":"5667_CR63","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","volume":"364","author":"HC Diener","year":"2004","unstructured":"Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ, MATCH investigators (2004) Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomized, double-blind, placebo-controlled trial. Lancet 364:331\u2013337","journal-title":"Lancet"},{"key":"5667_CR64","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","volume":"354","author":"DL Bhatt","year":"2006","unstructured":"Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Flather MD, Haffner SM, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Brennan DM, Fabry-Ribaudo L, Booth J, Topol EJ, CHARISMA Investigators (2006) Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 354:1706\u20131717","journal-title":"N Engl J Med"},{"key":"5667_CR65","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2007.03.025","volume":"49","author":"DL Bhatt","year":"2007","unstructured":"Bhatt DL, Flather MD, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Brennan DM, Fabry-Ribaudo L, Hu T, Topol Ej, Fox KA, CHARISMA Investigators (2007) Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol 49:1982\u20131988","journal-title":"J Am Coll Cardiol"},{"key":"5667_CR66","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/MJT.0b013e31814b17bf","volume":"16","author":"AS Weyrich","year":"2009","unstructured":"Weyrich AS, Skalabrin EJ, Kraiss LW (2009) Targeting the inflammatory response in secondary stroke prevention: a role for combing aspirin and extended-release dipyridamole. Am J Ther 16:164\u2013170","journal-title":"Am J Ther"},{"key":"5667_CR67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","volume":"143","author":"HC Diener","year":"1996","unstructured":"Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A (1996) European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 143:1\u201313","journal-title":"J Neurol Sci"},{"key":"5667_CR68","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(06)68734-5","volume":"367","author":"PH Halkes","year":"2006","unstructured":"ESPRIT Study Group, Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A (2006) Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomized controlled trial. Lancet 367:1665\u20131673 [published correction appears in Lancet 2007; 369:274]","journal-title":"Lancet"},{"key":"5667_CR69","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","volume":"359","author":"RL Sacco","year":"2008","unstructured":"Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahl\u00f6f B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, Vandermaelen C, Voigt T, Weber M, Yoon BW, PRoFESS Study Group (2008) Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 359:1238\u20131251","journal-title":"N Engl J Med"},{"key":"5667_CR70","unstructured":"U.S. National Institutes of Health. Warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00041938 . Accessed 12 Aug 2009"},{"key":"5667_CR71","unstructured":"U.S. National Institutes of Health. Aortic arch related cerebral hazard trial (ARCH). http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00235248 . Accessed 12 Aug 2009"},{"key":"5667_CR72","unstructured":"U.S. National Institutes of Health. Secondary prevention of small subcortical strokes (SPS3) trial. http:\/\/www.clinicaltrials.gov\/ct\/show\/NCT00059306 . Accessed 12 Aug 2009"},{"key":"5667_CR73","unstructured":"U.S. National Institutes of Health. Combination of clopidogrel and aspirin for prevention of early recurrence in acute atherothrombotic stroke (COMPRESS). http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00814268 . Accessed 12 Aug 2009"},{"key":"5667_CR74","unstructured":"U.S. National Institutes of Health. Clinicaltrial.gov. Platelet-Oriented Inhibition in New Transient Ischemic Attack (POINT) trial. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00991029 . Accessed 19 Nov 2009"},{"key":"5667_CR75","unstructured":"Stroke Trials Registry at University of Washington. RESPECT: randomized evaluation of recurrent stroke comparing PFO closure to established current standard of care treatment. http:\/\/www.strokecenter.org\/trials\/TrialDetail.aspx?tid=482 . Accessed 12 Aug 2009"},{"key":"5667_CR76","unstructured":"U.S. National Institutes of Health. Clinicaltrials.gov. Closure I. http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00201461?term=closure+i&rank=1 . Accessed 19 Nov 2009"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-010-5667-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-010-5667-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-010-5667-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:13:00Z","timestamp":1559056380000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-010-5667-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,22]]},"references-count":76,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["5667"],"URL":"https:\/\/doi.org\/10.1007\/s00415-010-5667-4","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,22]]}}}